SCHEMBL3010348

SCHEMBL3010348

FC(F)(F)Oc1cc(OBOc2ccc(Cl)c(OC(F)(F)F)c2)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.40
PDE3A Q14432 1/20 0.38
PGK1 P00558 1/20 0.35
EPHX1 P07099 1/20 0.34
SCN9A Q15858 2/20 0.33
GPR3 P46089 1/20 0.33
AKR1C2 P52895 1/20 0.33
AKR1C1 Q04828 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
GRIN2B Q13224 1/20 0.33
FFAR1 O14842 1/20 0.33
CYP2C9 P11712 1/20 0.33
SCN5A Q14524 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4A O75164 2/20 0.32
KDM5A P29375 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14237634 0.86 GPR3 (0.41) NOTUMPDE3AGPR3AKR1C2AKR1C1
SCHEMBL3409619 0.86 SCN9A (0.41) SCN9AGRIN2BPNLIPSLC1A5
SCHEMBL14237421 0.76 EPHX2 (0.46) SCN9AGPR3
SCHEMBL15521889 0.76 CA12 (0.43) CYP2C9FFAR4MAPTMAPK1L3MBTL1
SCHEMBL6090020 0.75 MRGPRX4 (0.44) SCN9AGPR3AKR1C2AKR1C1FFAR1
SCHEMBL177583 0.74 IDO1 (0.46) NOTUMSCN9A
SCHEMBL2997372 0.73 KCNK3 (0.39) GPR3
SCHEMBL8462016 0.73 NOTUM (0.44) NOTUMPDE3APGK1EPHX1GPR3
SCHEMBL9104112 0.72 FFAR1 (0.41) NOTUMEPHX1SCN9ATRPV1FFAR1
SCHEMBL249662 0.72 MAPT (0.45) NOTUMGPR3TRPV1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2010-08-05 US disclosed
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2008-10-09 US disclosed
EP-1844013-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-10-17 EP disclosed
EP-1841736-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-10-10 EP disclosed
WO-2006077367-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMATION BIOLIPOX AB (SE) 2006-07-27 WO disclosed
WO-2006077364-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, TPH1 NOTUM 4253/4885PDE3A 2481/4885PGK1 652/4885
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, ARG1 NOTUM 4246/4885PDE3A 2206/4885PGK1 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.